|
GRB2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.415600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.858000E-01 |
| Normal-vs-Stage2 |
2.084600E-01 |
| Normal-vs-Stage3 |
6.007600E-01 |
| Normal-vs-Stage4 |
5.811000E-01 |
| Stage1-vs-Stage2 |
2.943800E-01 |
| Stage1-vs-Stage3 |
8.423800E-01 |
| Stage1-vs-Stage4 |
4.036200E-01 |
| Stage2-vs-Stage3 |
4.110400E-01 |
| Stage2-vs-Stage4 |
1.655960E-01 |
| Stage3-vs-Stage4 |
3.841800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.281000E-01 |
| Normal-vs-AfricanAmerican |
7.624800E-01 |
| Normal-vs-Asian |
1.751840E-01 |
| Caucasian-vs-AfricanAmerican |
5.300000E-01 |
| Caucasian-vs-Asian |
7.227700E-02 |
| AfricanAmerican-vs-Asian |
2.663400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.309400E-01 |
| Normal-vs-Female |
3.817400E-01 |
| Male-vs-Female |
6.231900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.227200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.412200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.409000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.627800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.953000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.453000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.717200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.333600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.505600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.975200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.060600E-01 |
| Normal-vs-Grade 2 |
1.488200E-01 |
| Normal-vs-Grade 3 |
5.580200E-01 |
| Normal-vs-Grade 4 |
5.166000E-02 |
| Grade 1-vs-Grade 2 |
7.638300E-02 |
| Grade 1-vs-Grade 3 |
1.892790E-01 |
| Grade 1-vs-Grade 4 |
9.233200E-01 |
| Grade 2-vs-Grade 3 |
4.990800E-01 |
| Grade 2-vs-Grade 4 |
7.584600E-03 |
| Grade 3-vs-Grade 4 |
1.819580E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.285800E-01 |
| Normal-vs-ccB subtype |
8.903200E-01 |
| ccA subtype-vs-ccB subtype |
4.029800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.626800E-01 |
| Normal-vs-N1 |
1.160230E-02 |
| N0-vs-N1 |
1.105590E-02 |
|
|
